Management of iron deficiency in various clinical conditions and the role of intravenous iron: Recommendations of the Spanish erythropathology group of the Spanish society of hematology and hemotherapy

Publication date: Available online 25 December 2019Source: Revista Clínica Española (English Edition)Author(s): J.A. García Erce, A. Altés, M. López Rubio, Á.F. Remacha, en representación del Grupo Español de Eritropatología de la Sociedad Española de Hematología y HemoterapiaAbstractIron deficiency (ID) due to blood loss, absorption disorders and dietary deficiencies causes iron-deficiency anaemia, whose treatment seeks to eliminate the underlying cause and restore haemoglobin and iron deposits. Typically, the latter 2 of these objectives can be achieved through oral iron therapy. Intravenous iron administration (IIA) should be limited to those patients refractory or intolerant to oral preparations or who require rapid repletion. The indiscriminate use of IIA can increase morbidity and mortality due to iatrogenic overload. This fact, coupled with the growing popularity of IIA and the lack of reference guidelines in Spanish, led the Spanish Erythropathology Group of the Spanish Society of Haematology and Haemotherapy to develop this study, which presents the main recommendations on the optimal use of IIA in ID and attempts to constitute reference guidelines on good practices for the clinical management of these conditions.ResumenEl déficit de hierro (DH) a consecuencia de pérdidas de sangre, trastornos de absorción y/o carencias dietéticas, originan anemia ferropénica (AF), cuyo tratamiento persigue eliminar la causa subyacente, y restaurar la hemoglobina (Hb)...
Source: Revista Clinica Espanola - Category: Internal Medicine Source Type: research